chronic adult periodontitis periodontal disease periodontitis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age 18-80. Presence of at least one molar with furcation involvement 2 , with horizontal AL >3 mm and residual pocket after non-surgical therapy of >5 mm.
Exclusion criteria
Exclusion criteria: On a patient level: Uncontrolled diabetes, HIV, leukopenia, or any systemic diseases related to reduced healing potential. Allergy to any medication related with the study protocol (Paracetamol, Xilocaine). Pregnancy or lactation. Daily use of any medication suppressive for the immune system like corticosteroid or immunosuppressant. Antibiotics use before the study enrolment. ;On tooth level: Third molars. Terminal bone loss. Endodontically and non-Endodontically treated teeth with periapical radiolucency. Periapical radiolucency or vertical fracture. Mobility >1. Furcation involvement grade 0 or 1.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary aim is to evaluate if the adjunctive use of PRF during periodontal surgery (Open Flap Debridement + PRF) and the adjunctive use of EMD (Open Flap Debridement + EMD) improves the clinical outcomes (horizontal clinical attachment level, probing pocket depth, vertical clinical attachment level, bleeding on probing, bone fill) of furcation involved molars, compared to Open Flap Debridement alone (OFD). | — |
Secondary
| Measure | Time frame |
|---|---|
| The secondary aim is to clinically assess the wound healing process and to evaluate patient*s acceptance and morbidity of the different surgical procedures. The tertiary aim is to investigate a possible correlation of systemic (peripheral blood) and local (gingival crevicular fluid) immunological responses with the quality of early wound healing evaluation and final clinical results. | — |
Countries
Netherlands